IR Searcher

年度	タイプ	日付	売上高	営業利益	経常利益	純利益
2023-03	新規	2022-05-11	50000	1600	1600	1100
	修正	2022-11-09	50000(→)	1900(↑)	1900(↑)	1400(↑)
2024-03	新規	2023-05-10	53300	2000	2000	1300
2025-03	新規	2024-05-10	57000	2600	2300	1700
	修正	2024-11-11	60000(↑)	4000(↑)	3700(↑)	2600(↑)

通期四半期別

　※来期予想のグラフはQ1と表記されているがQ4である。

通期四半期別

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
予想		60000	4000	3700	2600		6.67%	6.17%	8.3%	103.7%	98.1%	88.7%
2025-03	2	29739	2434	2143	1535	179.75	8.18%	7.21%	8.4%	121.4%	95.2%	114.2%
	1	14622	1150	909	632	74.05	7.86%	6.22%	8.3%	95.1%	38.2%	31.9%
2024-03	4	55407	1964	1868	1377	159.98	3.54%	3.37%	8.6%	-11%	-15.7%	-14.2%
	3	42830	1843	1829	1227	141.92	4.3%	4.27%	9.2%	-6.3%	-11.2%	-17.8%
	2	27424	1099	1098	717	82.18	4.01%	4%	8.1%	-14.4%	-21.5%	-29.6%
	1	13507	589	658	479	54.71	4.36%	4.87%	9.2%	-5.2%	-15%	-14.2%
2023-03	4	51015	2206	2215	1605	183.07	4.32%	4.34%	2.8%	14.7%	11%	8.3%
	3	39219	1965	2060	1493	170.3	5.01%	5.25%	2.5%	1.8%	2.7%	-0.1%
	2	25371	1285	1399	1018	116.13	5.06%	5.51%	1.6%	2.5%	3.4%	-2.4%
	1	12367	622	774	559	63.76	5.03%	6.26%	-1.8%	1.6%	-0.8%	2.1%
2022-03	4	49632	1924	1996	1483	169.09	3.88%	4.02%	0.8%	-18.2%	-10.4%	-7.7%
	3	38271	1930	2006	1495	170.44	5.04%	5.24%	0.2%	-18.5%	-13.1%	-10.5%
	2	24966	1253	1353	1043	119	5.02%	5.42%	0.1%	-26.5%	-19.9%	-19.3%
	1	12599	612	780	547	62.45	4.86%	6.19%	1.4%	-36.7%	-22.7%	-24.1%
2021-03	4	49251	2351	2227	1607	183.18	4.77%	4.52%	5%	132.6%	108.8%	127.3%
	3	38212	2367	2309	1670	190.39	6.19%	6.04%	5.5%	135.6%	114.2%	133%
	2	24930	1705	1689	1293	147.4	6.84%	6.77%	5.3%	193.8%	169.1%	198.3%
	1	12430	967	1009	721	82.26	7.78%	8.12%	5.8%	101%	68.8%	75.8%
2020-03	4	46902	1010	1066	707	80.59	2.15%	2.27%	1.8%	-19.9%	-16.6%	-21%
	3	36229	1005	1078	716	81.69	2.77%	2.98%	1.7%	-19.1%	-15%	-18%
	2	23673	580	627	433	49.41	2.45%	2.65%	3.2%	-11.3%	-9.7%	-12%
	1	11748	481	598	410	46.77	4.09%	5.09%	3.4%	86.5%	64.6%	74.1%
2019-03	4	46074	1261	1279	894	101.96	2.74%	2.78%	0.4%	58%	53.7%	-7.7%
	3	35622	1242	1268	873	99.57	3.49%	3.56%	0.5%	58.2%	56.7%	-7.4%
	2	22950	654	695	492	56.16	2.85%	3.03%	-0.5%	100.4%	72.3%	85.6%

決算期	四半期	売上高	営業利益	経常利益	純利益	1株当たり純利益	営業利益率	経常利益率	売上高/前年比	営業利益/前年比	経常利益/前年比	純利益/前年比
予想	残	30261	1566	1557	1065	―	―	―	―	―	―
2025-03	2	15117	1284	1234	903	105.7	8.49%	8.16%	8.62%	151.76%	180.45%	279.41%
	1	14622	1150	909	632	74.05	7.86%	6.22%	8.3%	95.1%	38.2%	31.9%
2024-03	4	12577	121	39	150	18.06	0.96%	0.31%	6.62%	-49.79%	-74.84%	33.93%
	3	15406	744	731	510	59.74	4.83%	4.74%	11.25%	9.41%	10.59%	7.37%
	2	13917	510	440	238	27.47	3.66%	3.16%	7.02%	-23.08%	-29.6%	-48.15%
	1	13507	589	658	479	54.71	4.36%	4.87%	9.2%	-5.2%	-15%	-14.2%
2023-03	4	11796	241	155	112	12.77	2.04%	1.31%	3.83%	―	―	―
	3	13848	680	661	475	54.17	4.91%	4.77%	4.08%	0.44%	1.23%	5.09%
	2	13004	663	625	459	52.37	5.1%	4.81%	5.15%	3.43%	9.08%	-7.46%
	1	12367	622	774	559	63.76	5.03%	6.26%	-1.8%	1.6%	-0.8%	2.1%
2022-03	4	11361	-6	-10	-12	-1.35	―	―	2.92%	-62.5%	-87.8%	-80.95%
	3	13305	677	653	452	51.44	5.09%	4.91%	0.17%	2.27%	5.32%	19.89%
	2	12367	641	573	496	56.55	5.18%	4.63%	-1.06%	-13.14%	-15.74%	-13.29%
	1	12599	612	780	547	62.45	4.86%	6.19%	1.4%	-36.7%	-22.7%	-24.1%
2021-03	4	11039	-16	-82	-63	-7.21	―	―	3.43%	-420%	583.33%	600%
	3	13282	662	620	377	42.99	4.98%	4.67%	5.78%	55.76%	37.47%	33.22%
	2	12500	738	680	572	65.14	5.9%	5.44%	4.82%	645.45%	2244.83%	2386.96%
	1	12430	967	1009	721	82.26	7.78%	8.12%	5.8%	101%	68.8%	75.8%
2020-03	4	10673	5	-12	-9	-1.1	0.05%	―	2.11%	-73.68%	-209.09%	-142.86%
	3	12556	425	451	283	32.28	3.38%	3.59%	-0.92%	-27.72%	-21.29%	-25.72%
	2	11925	99	29	23	2.64	0.83%	0.24%	2.86%	-75%	-91.27%	-91.05%
	1	11748	481	598	410	46.77	4.09%	5.09%	3.4%	86.5%	64.6%	74.1%
2019-03	4	10452	19	11	21	2.39	0.18%	0.11%	0.06%	46.15%	-52.17%	-22.22%
	3	12672	588	573	381	43.41	4.64%	4.52%	2.29%	28.1%	41.13%	-43.81%
	2	11593	396	332	257	―	3.42%	2.86%	0.31%	118.78%	165.6%	252.05%

4538 扶桑薬品工業 企業サイト Yahooファイナンス 日経新聞 株探 四季報

4538 扶桑薬品工業　企業サイト　　　Yahooファイナンス　日経新聞　株探　四季報